Literature DB >> 20374740

Ribosomal protein S6 kinase from TOP mRNAs to cell size.

Oded Meyuhas1, Avigail Dreazen.   

Abstract

Ribosomal protein S6 kinase (S6K) has been implicated in the phosphorylation of multiple substrates and is subject to activation by a wide variety of signals that converge at mammalian target of rapamycin (mTOR). In the course of the search for its physiological role, it was proposed that S6K activation and ribosomal protein S6 (rpS6) phosphorylation account for the translational activation of a subgroup of transcripts, the TOP mRNAs. The structural hallmark of these mRNAs is an oligopyrimidine tract at their 5'-terminus, known as the 5'-TOP motif. TOP mRNAs consists of about 90 members that encode multiple components of the translational machinery, such as ribosomal proteins and translation factors. The translation efficiency of TOP mRNAs indeed correlates with S6K activation and rpS6 phosphorylation, yet recent biochemical and genetic studies have established that, although S6K and TOP mRNAs respond to similar signals and are regulated by mTOR, they maintain no cause and effect relationship. Instead, S6K is primarily involved in regulation of cell size, and affects glucose homeostasis, but is dispensable for global protein synthesis, whereas translational efficiency of TOP mRNAs is a determinant of the cellular protein synthesis capacity. Despite extensive studies of their function and mode of regulation, the mechanism underlying the effect of S6K on the cell size, as well as the trans-acting factor that mediates the translational control of TOP mRNAs, still await their identification.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20374740     DOI: 10.1016/S1877-1173(09)90003-5

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  57 in total

Review 1.  Are snoRNAs and snoRNA host genes new players in cancer?

Authors:  Gwyn T Williams; Farzin Farzaneh
Journal:  Nat Rev Cancer       Date:  2012-01-19       Impact factor: 60.716

2.  Activating the translational repressor 4E-BP or reducing S6K-GSK3β activity prevents accelerated axon growth induced by hyperactive mTOR in vivo.

Authors:  Xuan Gong; Longbo Zhang; Tianxiang Huang; Tiffany V Lin; Laura Miyares; John Wen; Lawrence Hsieh; Angélique Bordey
Journal:  Hum Mol Genet       Date:  2015-07-28       Impact factor: 6.150

3.  A pulse rapamycin therapy for infantile spasms and associated cognitive decline.

Authors:  Emmanuel Raffo; Antonietta Coppola; Tomonori Ono; Stephen W Briggs; Aristea S Galanopoulou
Journal:  Neurobiol Dis       Date:  2011-04-12       Impact factor: 5.996

4.  PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth.

Authors:  Jianyu Liu; Payton D Stevens; Xin Li; Micheal D Schmidt; Tianyan Gao
Journal:  Mol Cell Biol       Date:  2011-10-10       Impact factor: 4.272

5.  Blocking rpS6 Phosphorylation Exacerbates Tsc1 Deletion-Induced Kidney Growth.

Authors:  Huijuan Wu; Jianchun Chen; Jinxian Xu; Zheng Dong; Oded Meyuhas; Jian-Kang Chen
Journal:  J Am Soc Nephrol       Date:  2015-08-21       Impact factor: 10.121

6.  The mTOR Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury.

Authors:  Hassan Al-Ali; Ying Ding; Tatiana Slepak; Wei Wu; Yan Sun; Yania Martinez; Xiao-Ming Xu; Vance P Lemmon; John L Bixby
Journal:  J Neurosci       Date:  2017-06-16       Impact factor: 6.167

Review 7.  The expanding role of mTOR in cancer cell growth and proliferation.

Authors:  Marie Cargnello; Joseph Tcherkezian; Philippe P Roux
Journal:  Mutagenesis       Date:  2015-03       Impact factor: 3.000

8.  eRapa restores a normal life span in a FAP mouse model.

Authors:  Paul Hasty; Carolina B Livi; Sherry G Dodds; Diane Jones; Randy Strong; Martin Javors; Kathleen E Fischer; Lauren Sloane; Kruthi Murthy; Gene Hubbard; Lishi Sun; Vincent Hurez; Tyler J Curiel; Zelton Dave Sharp
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-26

9.  Two novel STK11 missense mutations induce phosphorylation of S6K and promote cell proliferation in Peutz-Jeghers syndrome.

Authors:  Ran Li; Zhiqing Wang; Shu Liu; Baoping Wu; Di Zeng; Yali Zhang; Lanbo Gong; Feihong Deng; Haoxuan Zheng; Yadong Wang; Chudi Chen; Junsheng Chen; Bo Jiang
Journal:  Oncol Lett       Date:  2017-11-17       Impact factor: 2.967

10.  Parallel measurement of dynamic changes in translation rates in single cells.

Authors:  Kyuho Han; Ariel Jaimovich; Gautam Dey; Davide Ruggero; Oded Meyuhas; Nahum Sonenberg; Tobias Meyer
Journal:  Nat Methods       Date:  2013-11-10       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.